| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.3 | 0.1 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |